Patent ID: 8754195

Claim:
A formulation, comprising: a) an aqueous carrier; b) 1 mg/ml to 100 mg/ml of an antibody or antibody fragment that specifically binds to PDGFR-alpha and inhibits growth of cells that express PDGFR-alpha, wherein said antibody or antibody fragment in said formulation has substantially similar reversible self-association (RSA) characteristics at 2-8° C. and 23-27° C., as determined by analytical ultracentrifugation (AUC); c) 4% to 20% (weight/volume) sucrose; d) 0.01% to 0.1% (weight/volume) polysorbate 80 (PS80); and e) sodium-acetate buffer, wherein said formulation has a pH of pH 4.0 to pH 6.0.